Data / Drug companies / Blistex Inc.
Blistex Inc.: 33 products in the FDA NDC directory, labeler code 10157
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Blistex Inc. (labeler code 10157) lists 33 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 33 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 1, 2026.
The request: Watch Blistex Inc. (FDA labeler code 10157): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 10157
- Products in commercial distribution
- 33
- Packages
- 73
- Finished drugs by generic name
- 18
- Prescription products
- 0
- Over the counter products
- 33
- Flagged as original packager
- 33 of 33 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- December 1, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 32 | 97% |
| Generic drugs (ANDA) | 1 | 3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 33 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 4 | 330 |
| Dimethicone, octinoxate, and octisalate | 4 | 1 |
| Tolnaftate | 2 | 99 |
| Witch hazel | 2 | 63 |
| Homosalate, octisalate, avobenzone, and dimethicone | 1 | 1 |
| Petrolatum | 1 | 74 |
| Dimethicone, unspecified, octinoxate, and octisalate | 1 | 1 |
| Benzocaine and zinc chloride | 1 | 1 |
| Benzocaine and menthol, unspecified form | 1 | 2 |
| Benzocaine and chloroxylenol | 1 | 1 |
| Benzocaine | 1 | 110 |
| Dimethicone, camphor (synthetic), menthol, and phenol | 1 | 1 |
| Zinc acetate and pramoxine hydrochloride | 1 | 9 |
| Dimethicone, avobenzone, homosalate, and octisalate | 1 | 1 |
| Glycerin, lidocaine, and witch hazel | 1 | 1 |
| Docosanol | 1 | 42 |
| Pramoxine hydrochloride | 1 | 15 |
| Glycerin and lidocaine | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Stick | 8 | 24.2% |
| Liquid | 6 | 18.2% |
| Ointment | 4 | 12.1% |
| Cream | 4 | 12.1% |
| Kit | 3 | 9.1% |
| Gel | 3 | 9.1% |
| Solution | 2 | 6.1% |
| Spray | 2 | 6.1% |
| Paste | 1 | 3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Blistex Maximum Hydration Lip | 10157-9913 | Ointment | Over the counter monograph drugs | July 1, 2026 |
| Odor-Eaters Athletes Foot | 10157-3100 | Cream | Over the counter monograph drugs | December 16, 2025 |
| Medicated Peppermint Lip Balm | 10157-4104 | Stick | Over the counter monograph drugs | August 1, 2025 |
| Cold Sore Fast-Acting Pain Relief | 10157-4103 | Gel | Over the counter monograph drugs | July 1, 2025 |
| Cold Sore Treatment Docosanol | 10157-2124 | Cream | Generic drugs (ANDA) | May 1, 2025 |
| Ivarest Poison Ivy Removal and Itch Relief | 10157-2125 | Liquid | Over the counter monograph drugs | February 1, 2025 |
| Kanka Triple Action | 10157-2127 | Gel | Over the counter monograph drugs | January 6, 2025 |
| Tucks Triple Relief Hemorrhoidal | 10157-2126 | Cream | Over the counter monograph drugs | January 6, 2025 |
| Lip Medex Cherry | 10157-1199 | Ointment | Over the counter monograph drugs | July 1, 2024 |
| Lip Medex Lip Balm | 10157-1194 | Stick | Over the counter monograph drugs | July 1, 2024 |
| Repair and Protect | 10157-1189 | Stick | Over the counter monograph drugs | July 5, 2023 |
| Stridex Essential | 10157-2119 | Liquid | Over the counter monograph drugs | December 6, 2022 |
| Stridex XL Face and Body Pads | 10157-2114 | Liquid | Over the counter monograph drugs | September 20, 2020 |
| Deep Renewal Broad Spectrum | 10157-1170 | Stick | Over the counter monograph drugs | September 9, 2020 |
| Blistex Five Star Lip Protection Broad Spectrum | 10157-1171 | Stick | Over the counter monograph drugs | August 22, 2020 |
| Blistex Medicated Lip Balm Variety Pack (Blistex Medicated Berry Lip Balm, Blistex Medicated Lip Balm, Blistex Medicated Lip) | 10157-9910 | Kit | Over the counter monograph drugs | February 3, 2020 |
| Blistex Medicated Lip Balm Variety Pack (Blistex Medicated Berry Lip Balm, Blistex Medicated Lip Balm, Blistex Medicated Mint Lip Balm) | 10157-9908 | Kit | Over the counter monograph drugs | February 3, 2020 |
| KANKA SoftBrush | 10157-2106 | Gel | Over the counter monograph drugs | September 25, 2019 |
| Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) | 10157-2112 | Kit | Over the counter monograph drugs | February 15, 2019 |
| Tucks Medicated Cooling Pads | 10157-2103 | Solution | Over the counter monograph drugs | August 30, 2018 |
| Blistex Medicated Berry Balm | 10157-1121 | Stick | Over the counter monograph drugs | January 15, 2018 |
| Blistex Medicated Mint Balm | 10157-1120 | Stick | Over the counter monograph drugs | January 15, 2018 |
| Blistex Medicated Lip Balm | 10157-1119 | Stick | Over the counter monograph drugs | January 15, 2018 |
| Blistex Lip Medex | 10157-8407 | Paste | Over the counter monograph drugs | March 28, 2017 |
| Tucks Medicated Cooling Pads | 10157-2103 | Solution | Over the counter monograph drugs | August 30, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.